Oct 10, 2016 11:00 am UTC| Business
BOSTON, Oct. 10, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced the presentation of preliminary data from the Company’s Phase 1b/2 study of Ad-RTS-hIL-12 + veledimex following standard chemotherapy for the...
Nova LifeStyle Announces Leadership Change
Oct 10, 2016 11:00 am UTC| Business
LOS ANGELES, Oct. 10, 2016 -- Nova LifeStyle, Inc. (NASDAQ:NVFY) (“Nova LifeStyle” or the “Company”), a U.S.-based, leading innovative designer, manufacturer and distributor of modern life style furniture, today...
Oct 10, 2016 11:00 am UTC| Business
Phase 2 Results in the Treatment of Macular Edema Associated with Retinal Vein Occlusion Phase 2 and Phase 1/2 Results in the Treatment of Macular Edema Associated with Non-Infectious Uveitis ALPHARETTA, Ga., Oct. 10,...
Oct 10, 2016 11:00 am UTC| Business
BEVERLY, Mass., Oct. 10, 2016 -- Cellceutix Corporation, (OTC: CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and...
Oct 10, 2016 11:00 am UTC| Business
-- Data, Including Developmental Milestones, as of September 15, 2016 as presented by Jerry Mendell, M.D. at the International Annual Congress of the World Muscle Society -- -- Webcast Today, October 10, 2016 at 8:30...
Oct 10, 2016 11:00 am UTC| Business
NUTH, The Netherlands and SAN DIEGO, Oct. 10, 2016 -- Fortimedix Surgical today announced the first-in-man use in the United States of FMX314, the world’s first single-port surgery solution that is compatible with a...
Great Basin Scientific Announces Transfer to the OTCQB Marketplace
Oct 10, 2016 11:00 am UTC| Business
SALT LAKE CITY, Oct. 10, 2016 -- Great Basin Scientific, Inc. (Nasdaq:GBSN), a molecular diagnostics company, announced today that its common stock will begin trading on the OTC Market Group’s OTCQB marketplace...